Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koh, K. B.
Right arrow Articles by Lee, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koh, K. B.
Right arrow Articles by Lee, B. K.

Psychosomatic Medicine, Vol 60, Issue 4 479-483, Copyright © 1998 by American Psychosomatic Society

ORIGINAL ARTICLES

Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders

KB Koh and BK Lee
Department of Psychiatry, Yonsei University College of Medicine, Seoul, Korea.

OBJECTIVE: The purpose of this study was to examine the effect of anxiety on cell-mediated immunity. METHOD: The subjects consisted of 31 patients with anxiety disorders and 31 normal controls, who were gender-matched. Cell-mediated immune function was measured by the lymphocyte proliferative response to phytohemagglutinin (PHA), Interleukin-2 (IL-2) production, and natural killer cell activity (NKA). The extent of anxiety was assessed by the Hamilton rating scale for anxiety and the anxiety subscale of symptom checklist-90 revised (SCL-90-R). RESULTS: The patients with anxiety disorders were significantly lower than the normal controls in lymphocyte proliferative response to PHA and IL-2 production. However, there was no significant difference in NKA between the two groups. Also, no significant correlation was found between the duration of illness or the degree of anxiety and each immune measure in patients with anxiety disorders. CONCLUSIONS: The results suggest a reduced cell-mediated immune function in patients with anxiety disorders, compared with normal controls. These findings also imply that a variety of immune measures should be assessed at the same time in this kind of psychoneuroimmunology research. This would help elucidate the relationship between anxiety and immune function, which has been unclear in most previous research using a single immune measure.


This article has been cited by other articles:


Home page
 Psychosom. Med.Home page
D. K. Thomsen, M. Y. Mehlsen, M. Hokland, A. Viidik, F. Olesen, K. Avlund, K. Munk, and R. Zachariae
Negative Thoughts and Health: Associations Among Rumination, Immunity, and Health Care Utilization in a Young and Elderly Sample
Psychosom Med, May 1, 2004; 66(3): 363 - 371.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
J. K. Kiecolt-Glaser, L. McGuire, T. F. Robles, and R. Glaser
Psychoneuroimmunology and Psychosomatic Medicine: Back to the Future
Psychosom Med, January 1, 2002; 64(1): 15 - 28.
[Abstract] [Full Text] [PDF]

Home page
 Occup. Environ. Med.Home page
A. Bargellini, A. Barbieri, S. Rovesti, R. Vivoli, R. Roncaglia, and P. Borella
Relation between immune variables and burnout in a sample of physicians
Occup. Environ. Med., July 1, 2000; 57(7): 453 - 457.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Psychosomatic Society